Clinical Trials Directory

Trials / Completed

CompletedNCT00779545

A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)

Dose Finding and Dose Regimen Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
455 (actual)
Sponsor
Organon and Co · Industry
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, randomized, double-blind within the dose level, parallel group comparison of mometasone furoate nasal spray in subjects with perennial allergic rhinitis to examine the minimal effective dose, the recommended dose, and the dosing regimen.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboOne, two, or four sprays of placebo are administered to the left and right nostrils twice a day (in the morning and at night) for 2 weeks.
DRUGMometasone furoateOne spray of mometasone furoate 50 mcg is administered to the left and right nostrils in the morning, and one spray of placebo to the left and right nostrils at night for 2 weeks. The daily dose of mometasone furoate is 100 mcg.
DRUGMometasone furoateTwo sprays of mometasone furoate 50 mcg are administered to the left and right nostrils in the morning, and two sprays of placebo to the left and right at night for 2 weeks. The daily dose of mometasone furoate is 200 mcg.
DRUGMometasone furoateFour sprays of mometasone furoate 50 mcg are administered to the left and right nostrils in the morning, and four sprays of placebo to the left and right nostrils at night for 2 weeks. The daily dose of mometasone furoate is 400 mcg.
DRUGMometasone furoateOne spray of mometasone furoate 50 mcg is administered to the left and right nostrils twice a day (in the morning and at night) for 2 weeks. The daily dose of mometasone furoate is 200 mcg.
DRUGMometasone furoateTwo sprays of mometasone furoate 50 mcg are administered to the left and right nostrils twice a day (in the morning and at night) for 2 weeks. The daily dose of mometasone furoate is 400 mcg.

Timeline

Start date
2004-04-08
Primary completion
2004-08-06
Completion
2004-08-06
First posted
2008-10-24
Last updated
2024-08-15

Source: ClinicalTrials.gov record NCT00779545. Inclusion in this directory is not an endorsement.